- $17.10bn
- $14.71bn
- $4.24bn
- 95
- 52
- 90
- 94
Annual cashflow statement for Incyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -296 | 949 | 341 | 598 | 32.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 191 | 223 | 306 | 224 | 161 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -71.7 | -14.6 | 199 | -249 | 138 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -125 | 749 | 970 | 496 | 335 |
| Capital Expenditures | -187 | -181 | -77.8 | -32.5 | -86.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -81.6 | -26.7 | -0.709 | -175 | 244 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -269 | -208 | -78.5 | -208 | 158 |
| Financing Cash Flow Items | -37.8 | -50 | -59 | -52.5 | -62.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 71.7 | 6.18 | -0.794 | -20 | -2,022 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -319 | 544 | 894 | 262 | -1,526 |